Clinical trial
Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD：a Multicentre Randomised Controlled Trial
NCT02937974 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD：a Multicentre Randomised Controlled Trial
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- December 31, 2018
- Enrollment
- 254 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.